Manmeet Ahluwalia MD, FACP, MBA
Deputy Director, Chief of Medical Oncology, and Chief Scientific Officer, Miami Cancer Institute, Miami, FloridaDr. Manmeet Ahluwalia is the Chief Scientific Officer, Chief of Medical Oncology, and Deputy Director and Fernandez Family Endowed Chair in Cancer Research at Baptist Health Miami Cancer Institute. Previously, he was the Dean and Diane Miller Family Endowed Chair in Neuro-Oncology in the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center (BBTC), Cleveland Clinic, Ohio, where he subspecialized in treatment of patients with brain tumors and brain metastases. He was also a Professor in the Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
A neuro-oncologist, Dr. Ahluwalia's research focuses on the development of new therapies for patients with brain tumors and brain metastases. He is currently leading several clinical trials involving new targeted therapies as well as immunotherapeutic approaches. His research has been presented nationally and internationally and has resulted in over 175 editorials, peer-reviewed manuscripts, and book chapters.
Recent Contributions to PracticeUpdate:
- Sequencing Checkpoint Inhibitors and Stereotactic Radiosurgery for Patients With Brain Metastases
- Ipilimumab and Nivolumab for Melanoma Brain Metastases
- Trial Updates on Pembrolizumab for Brain Cancer Metastases
- Larotrectinib for Central Nervous System Cancers With TRK Fusions
- Neratinib and Capecitabine for Patients With HER2+ Breast Cancer and Brain Metastases
- Increased Survival With Atezolizumab in Advanced NSCLC and Brain Metastases
- Using Steroids With Immunotherapy in Glioblastoma
- Novel Systemic Therapies for Brain Metastases From Lung Cancer
- Management of Brain Metastases in the Era of Checkpoint Inhibitors
- Survivin Vaccine for Newly Diagnosed GBM